These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 4547950)

  • 1. [Influence of various neurotropic drugs (L-dopa and alphamethyl-dopa) in Cushing's disease].
    González-Bárcena D; Siller-Rodríguez J; Guzmán-Rangel Y; López-Luna M
    Arch Invest Med (Mex); 1974; 5(2):99-104. PubMed ID: 4547950
    [No Abstract]   [Full Text] [Related]  

  • 2. Lack of responsiveness to L-dopa in Cushing's disease.
    Krieger DT
    J Clin Endocrinol Metab; 1973 Feb; 36(2):277-84. PubMed ID: 4345691
    [No Abstract]   [Full Text] [Related]  

  • 3. Diagnosis of Cushing's syndrome. The differentiation between adrenocortical hyperplasia and adrenocrotical adenoma by means of lysine-vasopressin.
    Bethge H; Bayer JM; Winkelmann W
    Acta Endocrinol (Copenh); 1969 Jan; 60(1):47-59. PubMed ID: 4308289
    [No Abstract]   [Full Text] [Related]  

  • 4. [I. Evaluation of the hypothalamo-hypophyseal-adrenal function. Effects of the administration of ACTH, dexamethasone, metopirone and L-dopa on the steroids of urine in normal patients].
    Charro Salgado AL; Bagazgoitia J; López Macia A; Oriol Bosch A; Fernández Cruz A
    Rev Clin Esp; 1976 May; 141(3):221-6. PubMed ID: 180569
    [No Abstract]   [Full Text] [Related]  

  • 5. Corticotropin releasing hormone: clinical endocrinology and implications for Cushing's disease and endogenous depression.
    Jaeckle RS; Lopez JF
    Psychiatr Med; 1985; 3(2):111-34. PubMed ID: 3037611
    [No Abstract]   [Full Text] [Related]  

  • 6. [Behavior of adrenocorticotropic internal secretions in Cushing's syndrome].
    Silvestrini F; D'Alonzo R
    Schweiz Med Wochenschr; 1970 Oct; 100(40):1680-4. PubMed ID: 4335210
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of cushing's disease with cypropheptadine (author's transl)].
    Michelsen H; Contreras P; Bradford I; Rojas A
    Rev Med Chil; 1977 Jun; 105(6):380-3. PubMed ID: 331429
    [No Abstract]   [Full Text] [Related]  

  • 8. Cushing's disease with periodic hormonogenesis: one explanation for paradoxical response to dexamethasone.
    Brown RD; Van Loon GR; Orth DN; Liddle GW
    J Clin Endocrinol Metab; 1973 Mar; 36(3):445-51. PubMed ID: 4346603
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prolonged remission in Cushing's syndrome following treatment with ortho-para-dichlordiphenyldichlorethane].
    Kirkegaard C; Kolendorf K
    Ugeskr Laeger; 1974 Jun; 136(25):1389-91. PubMed ID: 4366485
    [No Abstract]   [Full Text] [Related]  

  • 10. The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing's syndrome from pseudo-Cushing's states.
    Pecori Giraldi F; Pivonello R; Ambrogio AG; De Martino MC; De Martin M; Scacchi M; Colao A; Toja PM; Lombardi G; Cavagnini F
    Clin Endocrinol (Oxf); 2007 Feb; 66(2):251-7. PubMed ID: 17223996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cushing's syndrome in childhood.
    Killinger DW; Hudson RW; Volpé R
    Can Med Assoc J; 1972 Jan; 106(2):131-5. PubMed ID: 5058886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of large doses of reserpine on the hypothalamo-hypophyseal-adrenal system in Itsenko-Cushing's disease].
    Marova EI; Butrova SA; Kolesnikova GS
    Probl Endokrinol (Mosk); 1978; 24(2):17-21. PubMed ID: 205862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cushing's syndrome with amelioration during pregnancy.
    Lee R; Rapoport A
    JAMA; 1972 Jul; 221(4):392-6. PubMed ID: 5067844
    [No Abstract]   [Full Text] [Related]  

  • 14. [Case of Cushing's syndrome with remarkable daily fluctuation of urinary 17-OHCS].
    Inagaki H; Nakashio K; Koizumi S; Kogure H
    Nihon Rinsho; 1967 Nov; 25(11):2617-20. PubMed ID: 5628393
    [No Abstract]   [Full Text] [Related]  

  • 15. Lack of effect of antiserotoninergic and/or dopaminergic treatment in patients with pituitary-dependent Cushing's syndrome.
    Ambrosi B; Gaggini M; Secchi F; Faglia G
    Horm Metab Res; 1979 Apr; 11(4):318-9. PubMed ID: 222663
    [No Abstract]   [Full Text] [Related]  

  • 16. Hypothalamo-pituitary function in Pickwickian syndrome.
    Smirne S; Reschini E; Giustina G
    Bull Physiopathol Respir (Nancy); 1972; 8(5):1021-8. PubMed ID: 4657861
    [No Abstract]   [Full Text] [Related]  

  • 17. Cushing's syndrome. An evaluation of the clinical usefulness of urinary free cortisol and other urinary steroid measurements in diagnosis.
    Burke CW; Beardwell CG
    Q J Med; 1973 Jan; 42(165):175-204. PubMed ID: 4688791
    [No Abstract]   [Full Text] [Related]  

  • 18. Dexamethasone in nonsuppressible Cushing's disease.
    Meikle AW; West CD; Tyler FH
    N Engl J Med; 1980 Aug; 303(6):340. PubMed ID: 6247657
    [No Abstract]   [Full Text] [Related]  

  • 19. Pitfalls of functional tests for the establishment of the etiology of Cushing's syndrome in childhood and adolescence.
    Rivarola MA; Mendilaharzu H; Dahl V; Heinrich JJ; Spada RP; Mora H; Bergadá C; Cullen M
    J Clin Endocrinol Metab; 1970 Sep; 31(3):254-9. PubMed ID: 4318200
    [No Abstract]   [Full Text] [Related]  

  • 20. Cushing's disease: clinical and laboratory response to bromocriptine therapy.
    de Pinho MO; Antunes RC; Lima MB; Francalanci CC; Franco S
    J Endocrinol Invest; 1984 Dec; 7(6):585-8. PubMed ID: 6099377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.